{"podcast":{"title":"Squawk on the Street","slug":"squawk-on-the-street-731896","podcast_index_feed_id":731896,"rss_url":"https://feeds.simplecast.com/GcylmXl7","website_url":"https://www.cnbc.com","image_url":"https://image.simplecastcdn.com/images/92728f12-3d53-46b8-9a33-60e9b83ad72d/d37bc7cb-a0be-4376-bfba-896be0169c72/3000x3000/sots-podcast-cover-art-3000x3000-v04.jpg?aid=rss_feed","author":"CNBC","episode_count":2891,"summary":"CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer, David Faber and Sara Eisen is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds.","last_synced_at":"2026-07-18T04:20:00.197993+00:00","page_url":"https://stenobird.com/podcast/squawk-on-the-street-731896"},"episode":{"title":"11AM Hour: Kalshi CEO on Prediction Markets, Former Defense Secretary Mark Esper & Revolution Medicines CEO on Pancreatic Cancer Drug Breakthrough 6/1/26","slug":"11am-hour-kalshi-ceo-on-prediction-markets-former-defense-secretary-mark-esper-revolution-medicines-ceo-on-pancreatic-cancer-drug-breakthrough-6-1-26","published_at":"2026-06-01T16:21:53+00:00","page_url":"https://stenobird.com/podcast/squawk-on-the-street-731896/11am-hour-kalshi-ceo-on-prediction-markets-former-defense-secretary-mark-esper-revolution-medicines-ceo-on-pancreatic-cancer-drug-breakthrough-6-1-26","show_page_url":"https://stenobird.com/podcast/squawk-on-the-street-731896","url":"https://www.cnbc.com","audio_url":"https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/772daf2b-4aa5-445b-9969-6ecd181231b1/episodes/fce7f229-b60c-4bbf-9c9d-865c0215c724/audio/128/default.mp3?aid=rss_feed&awCollectionId=772daf2b-4aa5-445b-9969-6ecd181231b1&awEpisodeId=fce7f229-b60c-4bbf-9c9d-865c0215c724&feed=GcylmXl7","summary":"The CEO of Kalshi joins to discuss the company's latest product announcements and the regulatory environment for prediction markets. Then, Former Defense Secretary Mark Esper helps break down the latest headlines on the war with Iran. We also speak with the CEO of D-Wave Quantum following the U.S. government's recent investment in quantum companies. Plus, the CEO of Revolution Medicines joins to discuss the company's pancreatic cancer drug that nearly doubled survival rates. Squawk on the Street Disclaimer","meta_description":"The CEO of Kalshi joins to discuss the company's latest product announcements and the regulatory environment for prediction markets. Then, Former Defense…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2615,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/squawk-on-the-street-731896/episodes/11am-hour-kalshi-ceo-on-prediction-markets-former-defense-secretary-mark-esper-revolution-medicines-ceo-on-pancreatic-cancer-drug-breakthrough-6-1-26/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/squawk-on-the-street-731896/11am-hour-kalshi-ceo-on-prediction-markets-former-defense-secretary-mark-esper-revolution-medicines-ceo-on-pancreatic-cancer-drug-breakthrough-6-1-26.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}